Clinical Trials Logo

Gastric Variceal Bleeding clinical trials

View clinical trials related to Gastric Variceal Bleeding.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT00567216 Recruiting - Clinical trials for Gastric Variceal Bleeding

Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding

GVO-nadolol
Start date: April 2007
Phase: Phase 4
Study type: Interventional

Gastric variceal bleeding has a very high rebleeding rate even after endoscopic variceal injection of cyanoacrylate (GVO) which is considered the first choice of endoscopic treatment. Beta-blocker (BB) is effective to lower portal pressure. We hypothesized combination of GVO and BB can further decrease the rebleeding rate.